Focal therapy is a minimally invasive treatment indicated for localized prostate cancer. This procedure is based on treating only the areas of the prostate affected by the tumor, preserving the surrounding healthy tissue and thus reducing the impact of the treatment. In its modality with Focal One, uses high-intensity focused ultrasound (HIFU) to destroy exclusively the tumor tissue with maximum precision, offering an advanced, personalized, and highly selective technological alternative. Its main benefit is providing a treatment non-invasive, with maximum therapeutic precision, functional preservation and one very fast recovery, minimizing the side effects associated with more extensive treatments.
“Focal One therapy is positioned as one of the most innovative and distinctive technologies at Urovinci for the treatment of prostate cancer, with a near-zero rate of erectile dysfunction and urinary incontinence.”